Xinyan Lu

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia

Fibroblast growth factors.

Targeting apoptosis in cancer therapy

Isolation of Yeast Artificial Chromosomes Containing the Entire Transcriptional Unit of the Human FGF1 Gene

The myelodysplastic syndrome.

An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients

MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer

Untying the gordion knot of targeting MET in cancer

Artificial intelligence in healthcare

NF-κB: linking inflammation and immunity to cancer development and progression

Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets

Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic‐French Consortium Study

International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies

Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Coexistent genetic alterations involving ALK, RET, ROS1 or MET in 15 cases of lung adenocarcinoma

Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours

Additional–structural–chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience

Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome

Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution

Retrospective review of MET gene mutations

Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome